Literature DB >> 2842281

Establishment of megakaryoblastic cell lines by coinfection of Abelson murine leukemia virus and recombinant SV40-retrovirus.

S Kajigaya1, T Suda, J Suda, M Eguchi, M Moroi, T Sudo, M Saito, Y Miura.   

Abstract

Murine embryonic cells including yolk sac prepared from 8-day embryos were co-infected with Abelson murine leukemia virus (A-MuLV) and/or a recombinant retrovirus containing large T and small t antigens, and early region of simian virus 40 (M-SV40). By coinfection with A-MuLV and M-SV40, megakaryoblastic cells were obtained in addition to mast cells and fibroblastic cells. However, following infection with A-MuLV or M-SV40 alone, no megakaryoblastic cells were detected, although mast cells and/or fibroblastic cells developed. The same results were obtained in several experiments. By single-cell transfer, 6 acetyl-cholinesterase (AchE)-positive clonal cell lines were established. Characteristics of megakaryocytes, such as AchE, glycoproteins IIb and IIIa, and platelet peroxidase were detected in two representative cells (C1 and C8). More significant changes expressing differentiation were observed following treatment with phorbol myristate acetate or pokeweed mitogen-stimulated murine spleen cell conditioned medium, although release of platelets was not observed. This is the first report showing development of megakaryocytic cells as the result of coinfection with retroviruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842281      PMCID: PMC5917582          DOI: 10.1111/j.1349-7006.1988.tb02229.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  In vitro activation of the in vivo colony-forming units of the mouse yolk sac.

Authors:  G Perah; M Feldman
Journal:  J Cell Physiol       Date:  1977-05       Impact factor: 6.384

2.  Isolation and characterization of Abelson murine leukemia virus-transformed mast cell lines from midgestation embryonic placenta.

Authors:  M L Siegel; R Horwitz; T D Morris; R M Di Venere; E J Siden
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  The morphological and biochemical characterization of a line of rat promegakaryoblasts.

Authors:  R Weinstein; M B Stemerman; D E MacIntyre; H N Steinberg; T Maciag
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

8.  Normal rat cell lines deficient in nuclear thymidine kinase.

Authors:  W C Topp
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

9.  Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.

Authors:  J H Pierce; P P Di Fiore; S A Aaronson; M Potter; J Pumphrey; A Scott; J N Ihle
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

10.  Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome.

Authors:  M Ogura; Y Morishima; R Ohno; Y Kato; N Hirabayashi; H Nagura; H Saito
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

View more
  1 in total

1.  Establishment of an ES cell-derived murine megakaryocytic cell line, MKD1, with features of primary megakaryocyte progenitors.

Authors:  Hedia Chagraoui; Catherine Porcher
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.